Adverum Biotechnologies, Inc. (ADVM)
4.36
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Adverum Biotechnologies Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2025 | -1.598 |
| June 30, 2025 | -4.561 |
| March 31, 2025 | 3.526 |
| December 31, 2024 | 1.297 |
| September 30, 2024 | 0.5084 |
| June 30, 2024 | 0.4397 |
| March 31, 2024 | 0.4086 |
| December 31, 2023 | 1.101 |
| September 30, 2023 | 0.7353 |
| June 30, 2023 | 0.695 |
| March 31, 2023 | 0.6188 |
| December 31, 2022 | 0.5884 |
| September 30, 2022 | 0.5074 |
| June 30, 2022 | 0.4321 |
| March 31, 2022 | 0.3624 |
| December 31, 2021 | 0.3257 |
| September 30, 2021 | 0.3537 |
| June 30, 2021 | 0.3417 |
| March 31, 2021 | 0.0728 |
| December 31, 2020 | 0.0708 |
| September 30, 2020 | 0.0671 |
| June 30, 2020 | 0.1114 |
| March 31, 2020 | 0.1045 |
| December 31, 2019 | 0.1855 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.167 |
| June 30, 2019 | 0.1449 |
| March 31, 2019 | 0.1377 |
| December 31, 2018 | 0.0015 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.0022 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.013 |
| March 31, 2014 | -0.1972 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Anixa Biosciences, Inc. | 0.0127 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 72.40M |
| Total Liabilities (Quarterly) | 128.05M |
| Shareholders Equity (Quarterly) | -55.65M |